FDA label

What is Restoril used for?

Restoril contains temazepam. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “Restoril® (temazepam) is indicated for the short-term treatment of insomnia (generally 7 to 10 days).”

Run it in Rivvi

Which 2027 plans near you dropped or restricted Restoril?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Restoril, capsule

Indications and Usage, quoted from the label by SpecGx LLC (NDA018163). Cross-references to other label sections are left out.

Restoril® (temazepam) is indicated for the short-term treatment of insomnia (generally 7 to 10 days).

For patients with short-term insomnia, instructions in the prescription should indicate that Restoril® (temazepam) should be used for short periods of time (7 to 10 days).

The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.

Source: DailyMed label, set id bc56f7fd-1aaf-48ff-8aa7-d467e59e1015, version 25, effective June 9, 2026. NDC 0406-9914, one of 4 listings for this product.

Questions

What is Restoril used for?

The FDA label says: “Restoril® (temazepam) is indicated for the short-term treatment of insomnia (generally 7 to 10 days).”

What drug class is Restoril?

FDA lists temazepam in the Benzodiazepine established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Restoril

Try it on your own data today.

Free to start. Most teams are using it the same day.